Close menu

April 6th, 2023 | 09:44 CEST

Energy turnaround for your portfolio: RWE, GoviEx Uranium, Nordex

  • Mining
  • Uranium
  • renewableenergies
  • nuclear
Photo credits:

Clean energy is a dream for humanity. Property owners can fulfil the dream of clean energy by installing photovoltaic systems. But what about when large industrial companies, such as BASF, need electricity? While renewable energy has to be stored temporarily, nuclear power plants deliver reliably. The technology, which is frowned upon in Germany, is currently experiencing a revival worldwide. We explain which forms of energy also have a future for investors.

time to read: 4 minutes | Author: Nico Popp
ISIN: RWE AG INH O.N. | DE0007037129 , GOVIEX URANIUM INC A | CA3837981057 , NORDEX SE O.N. | DE000A0D6554

Table of contents:

    RWE: Despite wind power, it has not arrived in the future

    China, India, the USA and even Japan - all the countries mentioned are planning to build new nuclear power plants. In Germany, on the other hand, functional and safe reactors are being shut down. This is doubly paradoxical when, on the other side of the border, only a medium-distance cycle ride away, much older power plants in neighbouring countries continue to operate. Companies such as RWE stood for nuclear energy just a few years ago. Then came Fukushima and the nuclear phase-out. Today, companies like RWE are trying to give themselves as green an image as possible. Just a few months ago, RWE bought a lease off the coast of New York to build a wind power plant with a capacity of 3 GW. RWE is also active on the German coast and wants to realize a wind power plant with a capacity of 1.3 GW off Juist. In addition, RWE has a stake in the Brunsbüttel LNG terminal. So the Company got its act together pretty quickly after the outbreak of the war in Ukraine. However, RWE was partly caught on the wrong foot. Although it hedged against price fluctuations before the war and is sitting on futures contracts that have clearly gone into the money, the deliveries cannot be implemented because of the sanctions against Russia.

    Experts continue to assess RWE's future business as uncertain. The share of fossil fuels at RWE is still high. Although the nuclear phase-out has long been mastered except for a few legacy issues, the next construction site is now open. The share is not very interesting at the moment, and the dividend is no longer what it used to be. The former power plant operator now primarily trades in energy. Since countries are increasingly entering the market, this business is not a foregone conclusion either.

    GoviEX Uranium: Three promising projects - one share at the bottom

    The shares of GoviEx Uranium were anything but a sure-fire winner last year. The Company is pushing ahead with three projects in Zambia, Niger and Mali. Africa has always been a hot spot for uranium mining. For many years, French state-owned Areva mined uranium in Niger, among other places. The Madaouela project in Niger and the Muntanga project in Zambia are fully licensed for uranium mining, according to GoviEx. The former property also already has a feasibility study. GoviEx plans to start mining uranium in 2025 and emphasizes that it wants to become a producer in the current uranium cycle. Many smaller uranium companies will likely need much longer to reach this goal.

    The fact that it sometimes takes a very long time to bring uranium projects into production also creates a supply deficit that analysts expect to grow even larger in the coming years. Africa has a unique role to play in this context: the continent promises short routes to many regions of the world and is currently experiencing a charm offensive from Europe, the USA, and even China and Russia. The GoviEx Uranium share cannot be compared with large caps such as RWE - among other things, the market capitalization is significantly lower at around CAD 120 million. However, the three promising projects and the production planned for 2025 could make for an interesting mix for speculative investors. The share price has been falling for about a year and has stabilized recently. Those who believe in uranium and want to get their foot in the door can keep GoviEx Uranium in mind. However, entering in limited tranches and having an active risk management strategy is recommended.

    Nordex: Not putting the horsepower on the road

    Those who hedged profits from Nordex in the past half-year may have been stopped out on the stock recently. The wind turbine manufacturer from Germany is still posting losses and is struggling to monetize what should be a flourishing business, which Nordex does mainly abroad. Inflation and the general state of emergency have also caused costs to explode - until a Nordex wind turbine is delivered and installed, high costs are still being incurred. Looking at the Nordex share price over the long term, one can still see a downward trend. Those who believe in the turnaround can position themselves cautiously. However, the stock will only look really rosy if it can take the recent high of EUR 15 with momentum.

    Investments in energy are challenging. At first glance, companies like Nordex have everything they need to be successful. But then the costs really hit home. The situation is similar for old heavyweights like RWE: The transformation is difficult, and RWE still relies on fossil fuels. It is unlikely that stakes in LNG terminals will be the last word. And what about uranium? New power plants are being built all over the world. Many sources lie deep in the East. A supply shortfall is imminent. GoviEx Uranium is a small cap but has three promising projects with an ESG focus in three African countries. The stock is speculative but holds opportunities. If only one of the three projects comes into production, this alone should justify rising prices.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author

    Related comments:

    Commented by Juliane Zielonka on May 17th, 2024 | 07:00 CEST

    Almonty, Rheinmetall, Super Micro Computer - Commodity rally for defense and cloud

    • Mining
    • Tungsten
    • AI
    • Defense

    AI and defense stocks are setting the stock market on fire. Investors worldwide seem to have acquired a taste for artificial intelligence and defense. Wall Street is expecting a four-digit price target for Super Micro Computer soon. Rheinmetall is also enjoying full order books. Since the takeover of a Spanish ammunition manufacturer, production has also increased in this segment. Meanwhile, tensions between the largest economies, the USA and China, are growing enormously, which is reason enough for investors to take a look at Almonty Industries. The tungsten producer is on course for growth thanks to the restart of a mine in South Korea. Tungsten is rising in value as the increase in AI, and armaments are directly boosting demand for the rare earth metal. Who will win the stock market race?


    Commented by Fabian Lorenz on May 16th, 2024 | 08:00 CEST

    Share price shock at Siemens Energy! What are BioNTech and Cardiol Therapeutics doing?

    • Biotechnology
    • Pharma
    • renewableenergies

    The Siemens Energy share has been one of the surprises of recent months. It has more than doubled since the beginning of the year. Is a crash now imminent? Yes, if you believe Bernstein. Their analysts are shocking us with a horror price target. The Cardiol Therapeutics share performed even better than Siemens Energy in 2024. Despite the 150% rally, analysts see upside potential for the cardiovascular disease specialist. Things will get really exciting at the beginning of June when new study results are due. BioNTech, on the other hand, is currently failing to convince analysts. Reactions to the latest quarterly figures were modest.


    Commented by André Will-Laudien on May 16th, 2024 | 07:00 CEST

    Attention: Here we go! Hydrogen and uranium on the rise: Plug Power, Nel ASA, Kraken Energy and Siemens Energy in focus

    • Mining
    • Uranium
    • Hydrogen
    • renewableenergies
    • Energy

    It has finally happened! After months of sell-offs in hydrogen shares, there was a sigh of relief across the sector the day before yesterday. The reason: industry leader Plug Power received a government guarantee of USD 1.66 billion as backing for the construction of six-megawatt sites nationwide to create an initial hydrogen infrastructure. The Department of Energy (DOE) is thus demonstrating that the US is serious about investing in alternative energies. The decision boosted the entire energy sector, with uranium also continuing its recent upward trend. Where do the opportunities lie for investors?